Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc.

Healthcare

NASDAQ:TRVI · NASDAQ Global Market

Market Cap $2.06B Beta 1.05 P/E (TTM) -45.4
$14.21 +5.57%

+$0.75 today

52W Low $5.41High $16.12

Vol 1.51M · Avg 1.43M

EPS (TTM)-$0.31
Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+133.33%

Period High

$15.40

Period Low

$5.47

Latest

$14.21

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
TE

Terns Pharmaceuticals, Inc.

TERN

$4.77B

Zymeworks Inc.

Zymeworks Inc.

NASDAQ:ZYME

$1.68B

Novavax, Inc.

Novavax, Inc.

NASDAQ:NVAX

$1.46B

Ardelyx, Inc.

Ardelyx, Inc.

NASDAQ:ARDX

$1.41B

Precigen, Inc.

Precigen, Inc.

NASDAQ:PGEN

$1.34B

TR

Tourmaline Bio, Inc.

TRML

$1.23B

Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

NASDAQ:WVE

$1.13B

Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

NASDAQ:ZBIO

$883.93M

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

$856.09M

UP

Upstream Bio, Inc.

UPB

$331.96M

What is the latest TRVI filing?

The latest filing shown is 4 dated Jun 4, 2026.

How many recent filings does TRVI have?

Intrinsic Alpha currently shows 20 recent filings for TRVI.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.